A randomised double blind controlled trial of nitazoxanide in intestinal polyparasitism in humans: a Brazilian study

Completed

• Conditions: Intestinal polyparasitism; Infections and Infestations; Unspecified parasitic disease

• Registration Number: ISRCTN74820169
• Lead Sponsor: Federal University of Juiz de Fora (Brazil)

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2008-09-18
• Last Update Posted: 13 January 2015

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 60

Inclusion Criteria

1. Participants more than one year of age, either sex
2. Positive for one or more species of intestinal parasites
3. Rural populations in the Zona da Mata of the State of Minas Gerais (Brazil)
4. Taken care of by the Unified National Health System (SUS)

Exclusion Criteria

1. Intestinal obstruction for intestinal parasitisms
2. Pregnant
3. Patients with liver or renal insufficiency
4. Alterations in biliary treatment
5. Patient is using warfarin, aspirin, phenytoin, carbamazepine or valproic acid

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
1. Cure (non-infected) defined as an absence of any species of parasite in the examination of excrements<br>2. Cure absence (infected) defined as maintenance of the pre-existing parasite<br><br>These outcomes will be measured in July and September 2008.

Secondary Outcome Measures

Name	Time	Method
Prevalence of adverse effects. These outcomes will be measured in July and September 2008.